This is a StreetInsider.com Premium Only Page

Chembio Diagnostics (CEMI) – Press Releases

Oct 17, 2023 05:00 AM Life Science Outsourcing, Inc. Welcomes Neil A. Goldman as Chief Financial Officer

Apr 27, 2023 04:30 PM Biosynex Completes Acquisition of Chembio Diagnostics, Inc.

Apr 19, 2023 08:00 AM Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023

Apr 13, 2023 07:00 AM Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

Apr 10, 2023 08:00 AM Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023

Apr 3, 2023 04:15 PM Chembio’s CEO Letter to Stockholders

Mar 29, 2023 07:00 AM Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

Mar 21, 2023 07:00 AM Chembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023

Mar 15, 2023 07:00 AM Chembio Announces Letter to Stockholders Regarding Tender Offer

Mar 15, 2023 07:00 AM Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

Feb 24, 2023 08:00 AM Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System

Jan 31, 2023 05:00 PM Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

Nov 28, 2022 08:00 AM Chembio Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis System

Nov 3, 2022 04:05 PM Chembio Diagnostics Reports Third Quarter 2022 Financial Results

Oct 20, 2022 04:05 PM Chembio Diagnostics to Report Third Quarter 2022 Financial Results on November 3, 2022

Sep 6, 2022 08:00 AM Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay

Aug 16, 2022 08:00 AM Chembio Diagnostics Evaluates Monkeypox Rapid Point-of-Care Test Development

Aug 4, 2022 04:05 PM Chembio Diagnostics Reports Second Quarter 2022 Financial Results

Jul 21, 2022 04:05 PM Chembio Diagnostics to Report Second Quarter 2022 Financial Results on August 4, 2022

Jun 15, 2022 08:00 AM Chembio Diagnostics Announces Expansion of Direct-to-Consumer Commercial Channel

May 24, 2022 04:15 PM Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors

May 17, 2022 08:00 AM Chembio Diagnostics Announces Agreement for Reszon Diagnostics International to Manufacture Chembio’s HIV 1/2 STAT-PAK Assay at Chembio Diagnostics Malaysia Facility

May 5, 2022 04:05 PM Chembio Diagnostics Reports First Quarter 2022 Financial Results

Apr 21, 2022 04:05 PM Chembio Diagnostics to Report First Quarter 2022 Financial Results on May 5, 2022

Mar 3, 2022 04:05 PM Chembio Diagnostics Reports Fourth Quarter and Full Year 2021 Financial Results

Feb 17, 2022 04:05 PM Chembio Diagnostics to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022

Jan 6, 2022 04:05 PM Chembio Diagnostics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Jan 5, 2022 04:05 PM Chembio Diagnostics Announces Appointment of Larry Steenvoorden as Chief Financial Officer

Dec 6, 2021 08:00 AM Chembio Diagnostics Submits FDA De Novo/510(k) Request for DPP SARS-CoV-2 Antigen Test System

Nov 29, 2021 08:00 AM Chembio Diagnostics Receives SAHPRA Approval for DPP SARS-CoV-2 Antigen Test

Nov 22, 2021 08:00 AM Chembio Diagnostic Systems Prevails in International Arbitration Against BioSure (UK) Ltd

Nov 16, 2021 04:05 PM Chembio Diagnostics Submits EUA Application for New DPP SARS-CoV-2 Antigen Test

Nov 15, 2021 08:00 AM Chembio Diagnostics Announces Extension of Delivery Schedule for Bio Manguinhos Purchase Order of DPP SARS-COV-2 Antigen Tests

Nov 4, 2021 04:05 PM Chembio Diagnostics Reports Third Quarter 2021 Financial Results

Oct 21, 2021 04:50 PM Chembio Diagnostics to Report Third Quarter 2021 Financial Results on November 4, 2021

Oct 20, 2021 02:24 AM BioPorto A/S appoints new Chief Financial Officer

Sep 22, 2021 08:00 AM Chembio Announces EUA Submission for DPP Respiratory Antigen Panel

Aug 27, 2021 08:00 AM Chembio Launches Commercial Distribution of Third-Party COVID-19 Antigen Assay

Aug 5, 2021 04:05 PM Chembio Diagnostics Reports Second Quarter 2021 Financial Results

Jul 22, 2021 05:03 PM Chembio Diagnostics to Report Second Quarter 2021 Financial Results on August 5, 2021

Jul 22, 2021 12:49 PM Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund

Jul 20, 2021 10:56 PM Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil

May 6, 2021 04:05 PM Chembio Diagnostics Reports First Quarter 2021 Financial Results

Apr 22, 2021 08:00 AM Chembio Diagnostics to Report First Quarter 2021 Financial Results on May 6, 2021

Apr 1, 2021 05:30 PM Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu

Mar 11, 2021 04:05 PM Chembio Diagnostics Reports Fourth Quarter and Full Year 2020 Financial Results

Mar 8, 2021 08:00 AM Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors

Feb 25, 2021 04:05 PM Chembio Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021

Jan 14, 2021 07:00 AM Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems

Dec 17, 2020 04:05 PM Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors